Literature DB >> 12393795

Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport.

Janet Brownlees1, Steven Ackerley, Andrew J Grierson, Nick J O Jacobsen, Kerry Shea, Brian H Anderton, P Nigel Leigh, Christopher E Shaw, Christopher C J Miller.   

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common inherited disorder of the peripheral nervous system, and mutations in neurofilaments have been linked to some forms of CMT. Neurofilaments are the major intermediate filaments of neurones, but the mechanisms by which the CMT mutations induce disease are not known. Here, we demonstrate that CMT mutant neurofilaments disrupt both neurofilament assembly and axonal transport of neurofilaments in cultured mammalian cells and neurones. We also show that CMT mutant neurofilaments perturb the localization of mitochondria in neurones. Accumulations of neurofilaments are a pathological feature of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and diabetic neuropathy. Our results demonstrate that aberrant neurofilament assembly and transport can induce neurological disease, and further implicate defective neurofilament metabolism in the pathogenesis of human neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393795     DOI: 10.1093/hmg/11.23.2837

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  54 in total

1.  Cargo distributions differentiate pathological axonal transport impairments.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2012-01-25       Impact factor: 2.691

2.  Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.

Authors:  Hailian Shen; Devin M Barry; Jeffrey M Dale; Virginia B Garcia; Nigel A Calcutt; Michael L Garcia
Journal:  Hum Mol Genet       Date:  2011-04-14       Impact factor: 6.150

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Gel-expanded to gel-condensed transition in neurofilament networks revealed by direct force measurements.

Authors:  Roy Beck; Joanna Deek; Jayna B Jones; Cyrus R Safinya
Journal:  Nat Mater       Date:  2009-11-15       Impact factor: 43.841

Review 5.  Mitochondria: the next (neurode)generation.

Authors:  Eric A Schon; Serge Przedborski
Journal:  Neuron       Date:  2011-06-23       Impact factor: 17.173

6.  Ablation of cytoskeletal scaffolding proteins, Band 4.1B and Whirlin, leads to cerebellar purkinje axon pathology and motor dysfunction.

Authors:  Julia Saifetiarova; Manzoor A Bhat
Journal:  J Neurosci Res       Date:  2018-11-17       Impact factor: 4.164

7.  Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Authors:  Yueqin Zhou; Sharon Carmona; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Michael Vazquez; Ritchie Ho; Antonietta Franco; Bin Lu; Gerald W Dorn; Shaomei Wang; Cathleen M Lutz; Robert H Baloh
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

8.  Mitochondrial membrane potential is regulated by vimentin intermediate filaments.

Authors:  Ivan S Chernoivanenko; Elena A Matveeva; Vladimir I Gelfand; Robert D Goldman; Alexander A Minin
Journal:  FASEB J       Date:  2014-11-17       Impact factor: 5.191

Review 9.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 10.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.